
Validea's guru fundamental report on Intuitive Surgical (ISRG), a large-cap growth stock in the Medical Equipment & Supplies industry, indicates it scores 77% using the Martin Zweig Growth Investor model. This model prioritizes growth with accelerating earnings and sales, reasonable valuations, and low debt. While ISRG passes criteria such as revenue and EPS growth and debt-to-equity, its score falls below the 80% threshold for 'some interest' due to fails in areas like P/E ratio and earnings persistence.
Intuitive Surgical, Inc. (ISRG) receives a moderately positive assessment under Validea's Martin Zweig-based growth model, scoring 77%, which is just shy of the 80% threshold indicating significant interest. The analysis reveals a dichotomy in the company's profile: while ISRG exhibits strong current growth dynamics, it fails on key valuation and consistency metrics. Specifically, the company passes criteria for current quarter earnings, sales growth rate, and shows that current EPS growth is accelerating faster than both the prior three quarters and its historical rate. Furthermore, its financial health appears robust, as indicated by a passing score on its low total debt-to-equity ratio and positive insider transaction signals. However, the model flags significant concerns, most notably a 'FAIL' on its P/E ratio, suggesting a rich valuation. This is compounded by a 'FAIL' on 'Earnings Persistence' and 'Earnings growth rate for the past several quarters,' pointing to a history of inconsistent earnings performance despite the recent positive momentum.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment